ADVERTISEMENT

Health

Five years after COVID, pharma shares languish in U.S. policy limbo

Updated

Published

A vial of the Phase 3 Novavax coronavirus vaccine is prepared for a trial at St. George's University hospital in London on Oct. 7, 2020. (Alastair Grant / AP Photo)